MEKAWIRE
United States

Remedy Robotics

San Francisco developer of the N1, an AI-enabled robotic system for on-site, remote and autonomous endovascular procedures (investigational).

Remedy Robotics has raised $62M across 1 disclosed round since Nov 16, 2026; the latest round, Series B, was announced on Nov 16, 2026. Data as of Nov 17, 2026.

Headquartered in San Francisco, United States.

Latest from MEKAWIRE

InvestorTypeCountryRoundsLedFirstLatest
DCVCVenture capital—112026-11-162026-11-16
BioshoreVenture capital—102026-11-162026-11-16
BlackbirdVenture capital—102026-11-162026-11-16
Boost VCVenture capital—102026-11-162026-11-16
Build CollectiveVenture capital—102026-11-162026-11-16
CliffsVenture capital—102026-11-162026-11-16
Divergent CapitalVenture capital—102026-11-162026-11-16
HESTAVenture capital—102026-11-162026-11-16
HostplusVenture capital—102026-11-162026-11-16
KdT VenturesVenture capital—102026-11-162026-11-16
Oakwood Strategic CapitalVenture capital—102026-11-162026-11-16
Skip CapitalVenture capital—102026-11-162026-11-16
UC InvestmentsVenture capital—102026-11-162026-11-16

Related companies